Business Standard

Saturday, December 21, 2024 | 07:51 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Dr Lal Pathlabs consolidated net profit declines 26.50% in the March 2022 quarter

Image

Capital Market

Sales rise 12.65% to Rs 485.50 crore

Net profit of Dr Lal Pathlabs declined 26.50% to Rs 61.30 crore in the quarter ended March 2022 as against Rs 83.40 crore during the previous quarter ended March 2021. Sales rose 12.65% to Rs 485.50 crore in the quarter ended March 2022 as against Rs 431.00 crore during the previous quarter ended March 2021.

For the full year,net profit rose 18.24% to Rs 344.80 crore in the year ended March 2022 as against Rs 291.60 crore during the previous year ended March 2021. Sales rose 32.01% to Rs 2087.40 crore in the year ended March 2022 as against Rs 1581.30 crore during the previous year ended March 2021.

 
ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales485.50431.00 13 2087.401581.30 32 OPM %24.9428.31 -26.8627.59 - PBDT121.20131.10 -8 583.00471.60 24 PBT83.50110.80 -25 474.90394.40 20 NP61.3083.40 -26 344.80291.60 18

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 17 2022 | 5:34 PM IST

Explore News